Society guideline links: Female sexual dysfunction

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Menopause".)

International

●International Society for the Study of Women's Sexual Health (ISSWSH): Clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women (2021)

●ISSWSH: Review of epidemiology and pathophysiology, and a consensus nomenclature and process of care for the management of persistent genital arousal disorder/genito-pelvic dysesthesia (PGAD/GPD) (2021)

●Global consensus position statement on the use of testosterone therapy for women (2019)

●ISSWSH: Clinical practice guidelines on the process of care for the identification of sexual concerns and problems in women (2019)

●World Health Organization (WHO): A clinical handbook for care of girls and women living with female genital mutilation (2018)

●Definitions of sexual dysfunctions in women and men – A consensus statement from the Fourth International Consultation on Sexual Medicine 2015 (published 2016)

●WHO: Guidelines on the management of health complications from female genital mutilation (2016)

Canada

●North American Menopause Society (NAMS): The hormone therapy position statement (2022)

●NAMS: The genitourinary syndrome of menopause position statement (2020)

●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline on menopause and sexuality (2021)

●SOGC: Female sexual health consensus clinical guidelines (2018)

●Cancer Care Ontario (CCO): Interventions to address sexual problems in people with cancer (2016)

United States

●Centers for Disease Control and Prevention (CDC): Refugee health domestic guidance – Sexual and reproductive health: Female genital mutilation/cutting

●American College of Obstetricians and Gynecologists (ACOG) and American Society for Colposcopy and Cervical Pathology (ASCCP): Committee opinion on persistent vulvar pain (2016, reaffirmed 2024)

●American College of Radiology (ACR): ACR Appropriateness Criteria on acute pelvic pain in the reproductive age group (2023)

●ACOG: Committee opinion on adult manifestations of childhood sexual abuse (2011, reaffirmed 2022)

●North American Menopause Society (NAMS): The hormone therapy position statement (2022)

●American Institute of Ultrasound in Medicine (AIUM): Practice parameter for the performance of an ultrasound examination of the female pelvis (2020)

●NAMS: The genitourinary syndrome of menopause position statement (2020)

●ACOG: Practice bulletin on female sexual dysfunction (2019)

●ACR: ACR Appropriateness Criteria on postmenopausal subacute or chronic pelvic pain (2018)

Europe

●European guideline for the management of vulval conditions, 2021 (published 2022)

United Kingdom

●Royal College of Obstetricians and Gynaecologists (RCOG)/British Society of Urogynaecology (BSUG): Green-top guideline for management of bladder pain syndrome (2016)

●RCOG: Green-top guideline for female genital mutilation and its management (2015)

●RCOG: Green-top guideline for the initial management of chronic pelvic pain (2012)

Australia–New Zealand

●Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG): Clinical guidance statement on female genital mutilation/cutting (FGM/C) (1994, updated 2023)